/ Not yet recruitingPhase 3 XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome
XePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac arrest intensive care (which is targeted temperature management [TTM]) to xenon by inhalation plus standard-of-care post-cardiac arrest intensive care (including TTM).
100 Clinical Results associated with Invero Pharma
0 Patents (Medical) associated with Invero Pharma
100 Deals associated with Invero Pharma
100 Translational Medicine associated with Invero Pharma